Severe toxicities after irinotecan-based chemotherapy in a patient with lung cancer: A homozygote for the SLCO1B1*15 allele

Hiroshi Takane, Masanori Miyata, Naoto Burioka, Jun Kurai, Yasushi Fukuoka, Hisashi Suyama, Yasushi Shigeoka, Kenji Otsubo, Ichiro Ieiri, Eiji Shimizu

Research output: Contribution to journalArticlepeer-review

33 Citations (Scopus)

Abstract

Irinotecan is used widely in the treatment of several malignancies, but unpredictable severe toxicities such as myelosuppression and delayed-type diarrhea are sometimes experienced. Polymorphism of the UGT1A1 gene is one of the likely reasons for interindividual differences in irinotecan pharmacokinetics and severe toxicity. Also, polymorphic organic anion-transporting polypeptide 1B1 (OATP1B1, SLCO1B1) is reported to be involved in the hepatocellular uptake of SN-38. A 61-year-old man with lung cancer developed severe toxicities, including grade 3 diarrhea, grade 4 leukopenia, and grade 4 neutropenia, after the first cycle of irinotecan (60 mg/m) plus cisplatin chemotherapy. The irinotecan and SN-38 areas under the concentration-time curve from time zero to infinity in this patient were 43% and 87% higher than the corresponding mean values for 10 other patients with lung cancer treated with irinotecan (60-100 mg/m) normalized for the dose of irinotecan. Analysis of genetic variants in genes encoding the drug-metabolizing enzyme (UGT1A1) and transporter (SLCO1B1) involving irinotecan disposition revealed that this patient was homozygous for the SLCO1B1*15 allele, which may result in severe toxicities attributable to the extensive accumulation of SN-38. Screening of SLCO1B1*15 is suggested to be useful in irinotecan chemotherapy to avoid unpredicted severe toxicity, although the homozygous genotype is rare among the Japanese.

Original languageEnglish
Pages (from-to)666-668
Number of pages3
JournalTherapeutic drug monitoring
Volume29
Issue number5
DOIs
Publication statusPublished - Oct 1 2007

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Severe toxicities after irinotecan-based chemotherapy in a patient with lung cancer: A homozygote for the SLCO1B1*15 allele'. Together they form a unique fingerprint.

Cite this